Health Groups Oppose FDA’s Attempt to Limit Abortion Pill Access

A drug used to induce abortions should be accessible by mail while the the federal Food & Drug Administration appeals an order lifting its in-person dispensing requirement during the Covid-19 pandemic, women’s health-care providers told a federal appeals court.

The providers, including the American College of Obstetricians & Gynecologists, filed a response Tuesday to the FDA’s request that the U.S. Court of Appeals for the Fourth Circuit allow it to enforce a requirement that mifepristone be distributed only through hospitals, clinics, and doctor’s offices until the court decides if an injunction against it was properly granted.

Mifepristone is one of ...